Lower CSF orexin A (hypocretin-1) levels in patients with schizophrenia treated with haloperidol compared to unmedicated subjects

Mol Psychiatry. 2003 Oct;8(10):836-7. doi: 10.1038/sj.mp.4001363.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Antipsychotic Agents / therapeutic use*
  • Carrier Proteins / cerebrospinal fluid*
  • Female
  • Haloperidol / therapeutic use*
  • Humans
  • Intracellular Signaling Peptides and Proteins*
  • Male
  • Middle Aged
  • Neuropeptides / cerebrospinal fluid*
  • Orexins
  • Schizophrenia / cerebrospinal fluid*
  • Schizophrenia / drug therapy*

Substances

  • Antipsychotic Agents
  • Carrier Proteins
  • HCRT protein, human
  • Intracellular Signaling Peptides and Proteins
  • Neuropeptides
  • Orexins
  • Haloperidol